Handbook of multiple sclerosis
Author(s)
Bibliographic Information
Handbook of multiple sclerosis
(Neurological disease and therapy, 53)
M. Dekker, c2001
3rd ed.
- hc : alk. paper
Available at / 1 libraries
-
No Libraries matched.
- Remove all filters.
Note
Includes bibliographical references and index
Description and Table of Contents
Description
Reporting on the latest advances made in treating multiple sclerosis (MS) and continuing the high standards set by earlier editions, the Handbook of Multiple Sclerosis, Third Edition examines a wide range of topics from etiology to treatment options.
Analyzes recent developments in the natural history, immunopathology, lesion evolution, and therapy affecting MS treatment-including up-to-date research results from experimental therapies with t-cell vaccines, oral myelin, and monoclonal antibodies!
Summarizing previous breakthroughs and pointing the way toward future research, the Handbook of Multiple Sclerosis, Third Edition
provides a historical summary of the disease and examines the epidemiology and genetics of MS, including new evidence for and against an infectious etiology
investigates virus-induced demyelination, emphasizing models such as canine distemper (CDV), corona, visna, and herpes simplex viruses; the semliki forest virus (SFV); and animal models of autoimmune demyelination
notes the role of magnetic resonance imaging (MRI) in diagnosis, prognosis, natural history, and as a guide to therapy
explores the growing evidence for axonal damage as a major cause of disability in MS
summarizes the natural history of MS and delineates factors influencing exacerbations and progression of the disease
assesses current clinical and biological prognostic indicators for accurate diagnoses of MS as opposed to other idiopathic inflammatory demyelinating diseases (IIDDs) and evaluates the growing number of therapies for treating MS
and more!
Table of Contents
Etiopathogenesis
The History of Multiple Sclerosis
W. I. McDonald
The Epidemiology of Multiple Sclerosis
William Pryse-Phillips and Fiona Costello
The Genetics of Multiple Sclerosis
Jan Hillert and Thomas Masterman
Experimental Models of Virus-Induced Demyelination
Mauro C. Dal Canto
Evidence for a Viral Etiology of Multiple Sclerosis
Stuart D. Cook
Experimental Models of Autoimmune Demyelination
Fred D. Lublin
Evidence for Immunopathogenesis
Ute Traugott
Autoantibodies in Demyelinating Disease
Anne H. Cross, Jeri-Anne Lyons, and John L. Trotter
Clinical Pathologic Features
Clinical Features
Aaron E. Miller
Cognitive Impairment in Multiple Sclerosis
Jill S. Fischer
Loss and Restoration of Impulse Conduction in Disorders of Myelin
Stephen G. Waxman
Pathology of Multiple Sclerosis
John W. Prineas
Axonal Injury in Multiple Sclerosis
Carl Bjartmar and Bruce D. Trapp
Cerebrospinal Fluid
John N. Whitaker, Khurram Bashir, and Etty N. Benveniste
Laboratory Tests: Evoked Potentials
Marc R. Nuwer
Neuroimaging and the Use of Magnetic Resonance in Multiple Sclerosis
Lael A. Stone, Nancy Richert, and Henry McFarland
Therapeutic Considerations
The Natural History of Multiple Sclerosis
Sandra Vukusic and Christian Confavreux
Prognostic Factors in Multiple Sclerosis
Orhun H. Kantarci and Brian G. Weinshenker
Therapeutic Considerations: Rating Scales
Richard Rudick, Brian Weinshenker, and Gary Cutter
Therapeutic Considerations: Treatment of the Acute Exacerbation
Raymond Troiano
Interferon- -1b: Prophylactic Therapy in Multiple Sclerosis
Kenneth P. Johnson and Peter A. Calabresi
Therapeutic Considerations: Prophylactic Therapy with Interferon- -1a
Lawrence Jacobs
Prophylactic Therapy-Glatiramer Acetate (Copaxone (R))
Hillel Panitch
Treatment of Multiple Sclerosis with Intravenous Immunoglobulin
P. Rudge
Immunosuppressive Drugs
Mariko Kita and Donald E. Goodkin
Treatment of Multiple Sclerosis: Bone Marrow Reconstitution, Total Lymphoid Irradiation, and Plasma Exchange
George P. A. Rice
Symptomatic Therapy
Randall T. Schapiro
Symptomatic Treatment and Rehabilitation in Multiple Sclerosis
Charles R. Smith and Labe Scheinberg
Experimental Therapies with T-Cell Vaccines, Oral Myelin, and Monoclonal Antibodies in Multiple Sclerosis
Suprabha Bhat and Jerry S. Wolinsky
Future Immunotherapies
Christine Rohowsky-Kochan
by "Nielsen BookData"